SAN DIEGO--(BUSINESS WIRE)--Aug. 29, 2018--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps with continuous
glucose monitoring integration, today announced that Kim Blickenstaff,
president and CEO, will present a company update at the Baird 2018
Global Healthcare Conference in New York, NY. The presentation will take
place on Wednesday, September 5, 2018 at 1:25PM Eastern Time (10:25AM
The presentation will be webcast live and an archive recording will be
available for 30 days. The link to the live webcast and archive will be
accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem manufactures and sells the t:slim
X2™ Insulin Pump with Basal-IQ™ technology. The t:slim X2 Pump is
capable of remote feature updates using a personal computer and is the
only automated insulin delivery device approved for children as young as
6 years old. Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark, and t:slim X2 and
Basal-IQ are trademarks of Tandem Diabetes Care, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180829005577/en/
Source: Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc.